Enzyme-based medical products

Enzymatica

Enzymatica is based in Lund, Sweden, and sells medical devices against infectious diseases. The company's first product is ColdZyme® Munspray, which is marketed for cold virus prophylaxis and anti-cold virus therapeutic.

Financials

ENZYMATICA

SEKm 2017 2018 2019
Sales 59 49 56
Sales growth (%) 62,9 -17,9 15
EBITDA -22 -35 -22
EBITDA margin (%) -36,9 -72,5 -39,1
EBIT adj -30 -44 -27
EBIT adj margin (%) -50,8 -91 -48,6
Pretax profit -31 -44 -27
EPS rep -0,34 -0,47 -0,29
EPS growth (%) 50,2 -40,2 39,2
EPS adj -0,34 -0,47 -0,29
DPS 0 0 0
EV/EBITDA (x) -20,7 -6,5 -11,6
EV/EBIT adj (x) -15 -5,2 -9,4
P/E (x) -14,6 -4,4 -7,3
P/E adj (x) -14,6 -4,4 -7,3
EV/sales (x) 7,6 4,7 4,5
FCF yield (%) -5,2 -21,6 -12,7
Dividend yield (%) 0 0 0
Net IB debt/EBITDA 0,2 -1 -2,7

Main shareholders

Enzymatica

Main shareholders Share capital % Voting shares % Verified
Mats K Andersson 13.5 % 13.5 % 11 Jun 2018
Landsbankinn Hf. 10.3 % 10.3 % 30 Sep 2018
Gudmundur Palmasson 10.3 % 10.3 % 15 Mar 2017
Agusta Gudmundsdottir 9.8 % 9.8 % 31 Dec 2016
Håkan Roos 6.9 % 6.9 % 30 Sep 2018
Fibonacci Asset Management AB 6.7 % 6.7 % 30 Sep 2018
Ulf Blom 2.2 % 2.2 % 30 Sep 2018
Jörgen Rexö 2.2 % 2.2 % 30 Sep 2018
Avanza Pension 2.2 % 2.2 % 30 Sep 2018
Nordnet Pensionsförsäkring 1.9 % 1.9 % 30 Sep 2018

Insider list

Enzymatica

Name
Sigurgeir Gudlaugsson
Sigurgeir Gudlaugsson
Sigurgeir Gudlaugsson
Sigurgeir Gudlaugsson
Sigurgeir Gudlaugsson
Sigurgeir Gudlaugsson
Medzyme Invest Öresund AB
Mats Kristian Andersson
Mats Kristian Andersson
Mats Kristian Andersson
Show More